JP2013530208A5 - - Google Patents

Download PDF

Info

Publication number
JP2013530208A5
JP2013530208A5 JP2013517583A JP2013517583A JP2013530208A5 JP 2013530208 A5 JP2013530208 A5 JP 2013530208A5 JP 2013517583 A JP2013517583 A JP 2013517583A JP 2013517583 A JP2013517583 A JP 2013517583A JP 2013530208 A5 JP2013530208 A5 JP 2013530208A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
topical administration
administration
day
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013517583A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013530208A (ja
JP5858994B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2011/001919 external-priority patent/WO2012004669A1/en
Publication of JP2013530208A publication Critical patent/JP2013530208A/ja
Publication of JP2013530208A5 publication Critical patent/JP2013530208A5/ja
Application granted granted Critical
Publication of JP5858994B2 publication Critical patent/JP5858994B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013517583A 2010-07-08 2011-07-08 口唇ヘルペス、性器ヘルペス、および帯状疱疹の再発を抑制するためのポリエチレングリコール組成物 Active JP5858994B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36232910P 2010-07-08 2010-07-08
US61/362,329 2010-07-08
PCT/IB2011/001919 WO2012004669A1 (en) 2010-07-08 2011-07-08 Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster

Publications (3)

Publication Number Publication Date
JP2013530208A JP2013530208A (ja) 2013-07-25
JP2013530208A5 true JP2013530208A5 (cg-RX-API-DMAC7.html) 2014-07-31
JP5858994B2 JP5858994B2 (ja) 2016-02-10

Family

ID=44588123

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013517583A Active JP5858994B2 (ja) 2010-07-08 2011-07-08 口唇ヘルペス、性器ヘルペス、および帯状疱疹の再発を抑制するためのポリエチレングリコール組成物

Country Status (20)

Country Link
US (2) US9814743B2 (cg-RX-API-DMAC7.html)
EP (1) EP2563374B1 (cg-RX-API-DMAC7.html)
JP (1) JP5858994B2 (cg-RX-API-DMAC7.html)
KR (1) KR101881175B1 (cg-RX-API-DMAC7.html)
CN (1) CN103079574B (cg-RX-API-DMAC7.html)
AU (1) AU2011275458B2 (cg-RX-API-DMAC7.html)
CA (1) CA2803228C (cg-RX-API-DMAC7.html)
DK (1) DK2563374T3 (cg-RX-API-DMAC7.html)
ES (1) ES2442928T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20140135T1 (cg-RX-API-DMAC7.html)
IL (1) IL223582A (cg-RX-API-DMAC7.html)
MX (1) MX2012014783A (cg-RX-API-DMAC7.html)
PL (1) PL2563374T3 (cg-RX-API-DMAC7.html)
PT (1) PT2563374E (cg-RX-API-DMAC7.html)
RS (1) RS53162B (cg-RX-API-DMAC7.html)
RU (1) RU2643763C2 (cg-RX-API-DMAC7.html)
SG (1) SG186937A1 (cg-RX-API-DMAC7.html)
SI (1) SI2563374T1 (cg-RX-API-DMAC7.html)
WO (1) WO2012004669A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201300177B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2442928T3 (es) 2010-07-08 2014-02-14 Devirex Ag Composiciones de polietilenglicol para controlar las recidivas de herpes labialis, herpes genitalis y herpes zoster
WO2013102885A1 (en) 2012-01-06 2013-07-11 Devirex Ag Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
US9084740B2 (en) 2013-02-19 2015-07-21 Johnson & Johnson Consumer Companies, Inc. Methods and compositions for improving appearance and formation of scar tissue
EP2803354B1 (de) * 2013-05-14 2015-03-04 NajöPharm GmbH i.G. Kombination aus Polyacrylsäure und 2-Amino-2-methylpropanol zur Verwendung in der Behandlung von Herpesinfektionen
UY37497A (es) * 2016-11-28 2018-06-29 Aicuris Anti Infective Cures Gmbh Formulación tópica que comprende n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil]-acetamida
CN114981286A (zh) 2019-05-03 2022-08-30 豪夫迈·罗氏有限公司 降低从纯化平台获得的组合物中酶水解活性速率的方法
US20210330700A1 (en) * 2020-04-23 2021-10-28 Johnson & Johnson Consumer Inc. Methods and compositions for inhibiting influenza viruses using low molecular weight hydrophobically modified polymers and polyalkylene glycols
EP4355297A1 (de) * 2020-04-30 2024-04-24 Ninoderm UG (Haftungsbeschränkt) Behandlungsmittel zur antiviralen therapie, applikator und verfahren zur herstellung eines behandlungsmittels

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603122A (en) 1979-08-17 1986-07-29 Blough Herbert A Antiviral agent against herpes virus infections
GB2080682B (en) * 1980-07-30 1984-03-28 Ciba Geigy Ag Antiherpetically active lipstick
EP0087161A3 (en) * 1982-02-24 1984-04-04 Key Pharmaceuticals, Inc. Isopropylmyristate 4-alkyl-2,6-(bis-tert-butyl)-phenol medicament
US5232700A (en) * 1990-11-14 1993-08-03 The Administrators Of The Tulane Educational Fund Methods of prophylaxis and treatment of herpes simplex lesions utilizing piracetam as the active ingredient
NL9500216A (nl) * 1995-02-06 1996-09-02 Bio Pharma Sciences Bv Farmaceutische samenstelling voor de behandeling van herpes.
US6045823A (en) * 1996-09-19 2000-04-04 Dragoco Gerberding & Co. Ag Process for producing solid anhydrous composition, and pharmaceutical and cosmetic products comprising same
GB9902227D0 (en) * 1999-02-01 1999-03-24 Cipla Limited Pharmaceutical composition for topical administration
US8030260B2 (en) * 2005-03-25 2011-10-04 Chemsil Silicones, Inc Pre-shave compositions and methods of using same
DE202005007363U1 (de) 2005-05-04 2005-07-14 Anton Hübner GmbH & Co. KG Gegen Herpesbläschen verwendbare Kieselsäurezusammensetzungen
JP2010516646A (ja) 2007-01-17 2010-05-20 デヴィレックス アーゲー シクロデキストリン処方物
ES2442928T3 (es) 2010-07-08 2014-02-14 Devirex Ag Composiciones de polietilenglicol para controlar las recidivas de herpes labialis, herpes genitalis y herpes zoster
WO2013102885A1 (en) 2012-01-06 2013-07-11 Devirex Ag Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster

Similar Documents

Publication Publication Date Title
JP2013530208A5 (cg-RX-API-DMAC7.html)
JP2016538271A5 (cg-RX-API-DMAC7.html)
JP2009286795A5 (cg-RX-API-DMAC7.html)
BR112014014262A2 (pt) nanopartículas; composição farmacêutica; método de administrar um ou mais agentes terapêuticos, profiláticos, e/ou diagnósticos a um paciente em necessidade dos mesmos e método de preparação das partículas.
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
EP4316488A3 (en) Methods and compositions for treatment of attention deficit disorder
JP2012515184A5 (cg-RX-API-DMAC7.html)
WO2013101897A3 (en) Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
FI3562486T3 (fi) Kielenalaisen deksmedetomidiinin käyttö agitaation hoidossa
JP2014530874A5 (cg-RX-API-DMAC7.html)
JP2013518057A5 (cg-RX-API-DMAC7.html)
WO2010084115A3 (en) Antiviral agents
WO2012098562A3 (en) Liquid oral compositions of lanthanum salts
GEP20166488B (en) Co-crystals and salts of ccr3-inhibitors
JP2016539156A5 (cg-RX-API-DMAC7.html)
JP2012517478A5 (cg-RX-API-DMAC7.html)
UA111599C2 (uk) Композиція каспофунгіну
JP2014526559A5 (cg-RX-API-DMAC7.html)
HRP20191723T1 (hr) Nukleotid dims0-150 za primjenu u liječenju kroničnog aktivnog ulceroznog kolitisa
RU2013100383A (ru) Композиции полиэтиленгликоля для контроля рецидивов лабиального герпеса, генитального герпеса и опоясывающего герпеса
WO2007133796A3 (en) Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist
WO2013019091A3 (en) A COMPOUND FOR INHIBITING 11β-HYDROXY STEROID DEHYDROGENASE 1, AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
JP2015507020A5 (cg-RX-API-DMAC7.html)
JP2007119497A5 (cg-RX-API-DMAC7.html)
EP2575456A4 (en) COMPOSITIONS AND METHODS FOR TREATING PRESENTATIONS